184 related articles for article (PubMed ID: 25312247)
1. Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients.
Helin-Toiviainen M; Rönkkö S; Puustjärvi T; Rekonen P; Ollikainen M; Uusitalo H
Acta Ophthalmol; 2015 Mar; 93(2):165-71. PubMed ID: 25312247
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma.
Rönkkö S; Rekonen P; Kaarniranta K; Puustjärvi T; Teräsvirta M; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):697-704. PubMed ID: 17028863
[TBL] [Abstract][Full Text] [Related]
3. Phospholipases A2 in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma.
Helin M; Rönkkö S; Puustjärvi T; Teräsvirta M; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):739-46. PubMed ID: 18196260
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma.
Määttä M; Tervahartiala T; Harju M; Airaksinen J; Autio-Harmainen H; Sorsa T
J Glaucoma; 2005 Feb; 14(1):64-9. PubMed ID: 15650607
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study.
Ollikainen M; Puustjärvi T; Rekonen P; Uusitalo H; Teräsvirta M
Acta Ophthalmol; 2010 Feb; 88(1):20-6. PubMed ID: 19432842
[TBL] [Abstract][Full Text] [Related]
6. MMP expression in leaking filtering blebs and tears after glaucoma filtering surgery.
Mathalone N; Marmor S; Rahat MA; Lahat N; Oron Y; Geyer O
Graefes Arch Clin Exp Ophthalmol; 2011 Jul; 249(7):1047-55. PubMed ID: 21452038
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low-density lipoprotein, lipid and calcium aggregates reveal oxidative stress and inflammation in the conjunctiva of glaucoma patients.
Helin-Toiviainen M; Rönkkö S; Kaarniranta K; Puustjärvi T; Rekonen P; Ollikainen M; Uusitalo H
Acta Ophthalmol; 2017 Jun; 95(4):378-385. PubMed ID: 28139882
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma.
Schlötzer-Schrehardt U; Lommatzsch J; Küchle M; Konstas AG; Naumann GO
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1117-25. PubMed ID: 12601038
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.
Rönkkö S; Rekonen P; Kaarniranta K; Puustjarvi T; Teräsvirta M; Uusitalo H
Mol Vis; 2007 Mar; 13():408-17. PubMed ID: 17417602
[TBL] [Abstract][Full Text] [Related]
10. Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study.
Ollikainen ML; Puustjärvi TJ; Rekonen PK; Uusitalo HM; Teräsvirta ME
Acta Ophthalmol; 2011 Sep; 89(6):548-55. PubMed ID: 19925527
[TBL] [Abstract][Full Text] [Related]
11. TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.
Ashworth Briggs EL; Toh T; Eri R; Hewitt AW; Cook AL
Mol Vis; 2015; 21():1162-72. PubMed ID: 26539028
[TBL] [Abstract][Full Text] [Related]
12. Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma.
Määttä M; Tervahartiala T; Vesti E; Airaksinen J; Sorsa T
J Glaucoma; 2006 Jun; 15(3):229-37. PubMed ID: 16778646
[TBL] [Abstract][Full Text] [Related]
13. Deep sclerectomy for the treatment of exfoliation and primary open-angle glaucoma.
Rekonen P; Kannisto T; Puustjärvi T; Teräsvirta M; Uusitalo H
Acta Ophthalmol Scand; 2006 Aug; 84(4):507-11. PubMed ID: 16879572
[TBL] [Abstract][Full Text] [Related]
14. Conjunctival inflammatory cells and their predictive role for deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma.
Helin M; Rönkkö S; Puustjärvi T; Teräsvirta M; Ollikainen M; Uusitalo H
J Glaucoma; 2011 Mar; 20(3):172-8. PubMed ID: 20577105
[TBL] [Abstract][Full Text] [Related]
15. Altered transcripts expression of matrix metalloproteinases and their tissue inhibitors in tenon capsule of patients with glaucoma.
Liu CJ; Huang YL; Ju JP; Lu CL; Chiu AW
J Glaucoma; 2004 Dec; 13(6):486-91. PubMed ID: 15534474
[TBL] [Abstract][Full Text] [Related]
16. Deep sclerectomy in primary open-angle glaucoma and exfoliative glaucoma.
Suominen SM; Harju MP; Vesti ET
Eur J Ophthalmol; 2016 Nov; 26(6):568-574. PubMed ID: 26951530
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of patients with primary angle closure glaucoma - a quantitative study.
Nga AD; Yap SL; Samsudin A; Abdul-Rahman PS; Hashim OH; Mimiwati Z
BMC Ophthalmol; 2014 Mar; 14():33. PubMed ID: 24655889
[TBL] [Abstract][Full Text] [Related]
18. Effect of latanoprost and timolol on the histopathology of the human conjunctiva.
Terai N; Schlötzer-Schrehardt U; Lampel J; Böhm AG; Rummelt C; Schmidt E; Pillunat LE
Br J Ophthalmol; 2009 Feb; 93(2):219-24. PubMed ID: 18971237
[TBL] [Abstract][Full Text] [Related]
19. Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissue.
Ito T; Ohguro H; Mamiya K; Ohguro I; Nakazawa M
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):823-30. PubMed ID: 16505013
[TBL] [Abstract][Full Text] [Related]
20. Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface.
Honda N; Miyai T; Nejima R; Miyata K; Mimura T; Usui T; Aihara M; Araie M; Amano S
Arch Ophthalmol; 2010 Apr; 128(4):466-71. PubMed ID: 20385943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
